Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Indianapolis, IN
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Lake Charles, LA
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Cumberland, MD
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Cumberland, MD
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Hagerstown, MD
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Hagerstown, MD
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Battle Creek, MI
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Battle Creek, MI
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Lansing, MI
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Jackson, MS
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Tupelo, MS
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Tupelo, MS
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Lincoln, NE
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
New York, NY
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
North Charleston, SC
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
North Charleston, SC
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Jackson, TN
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Mesquite, TX
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Mesquite, TX
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Tacoma, WA
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
Clinical Research Facility
mi
from
Clarksburg, WV
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
Clinical Research Facility
mi
from
Clarksburg, WV
Click here to add this to my saved trials
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated:  11/5/2015
mi
from
Buenos Aires,
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
A Randomized, Controlled Study of Sarilumab and Methotrexate (MTX) Versus Etanercept and MTX in Patients With Rheumatoid Arthritis (RA) and an Inadequate Response to 4 Months of Treatment With Adalimumab and MTX
Status: Enrolling
Updated: 11/5/2015
mi
from
Buenos Aires,
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Rheumatology Associates, PC
mi
from
Birmingham, AL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rheumatology Associates, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Coastal Clinical Research Inc
mi
from
Mobile, AL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Advanced Arthritis Care and Research
mi
from
Scottsdale, AZ
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Advanced Arthritis Care and Research
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Catalina Pointe Clinical Research
mi
from
Tucson, AZ
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Catalina Pointe Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
St. Joseph'S Mercy Clinic
mi
from
Hot Springs, AR
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
St. Joseph'S Mercy Clinic
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Talbert Medical Group
mi
from
Huntington Beach, CA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Talbert Medical Group
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Allergy and Rheumatology Medical Clinic Inc
mi
from
La Jolla, CA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Allergy and Rheumatology Medical Clinic Inc
mi
from
La Jolla, CA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Valerius Medical Group And Research Center Of Greater Long Beach, Inc.
mi
from
Long Beach, CA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Valerius Medical Group And Research Center Of Greater Long Beach, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Stanford University School of Medicine
mi
from
Palo Alto, CA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
San Diego Arthritis Medical Clinic
mi
from
San Diego, CA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
San Diego Arthritis Medical Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Boulder Medical Center
mi
from
Boulder, CO
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Boulder Medical Center
mi
from
Boulder, CO
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Arthritis Assoc And Osteo Ctr Of Col Sprgs
mi
from
Colorado Springs, CO
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis Assoc And Osteo Ctr Of Col Sprgs
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Denver Arthritis Clinic
mi
from
Denver, CO
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Denver Arthritis Clinic
mi
from
Denver, CO
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Arthritis Center Of The Rockies, Pc
mi
from
Loveland, CO
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis Center Of The Rockies, Pc
mi
from
Loveland, CO
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Guadagnoli, Germano
mi
from
Bridgeport, CT
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Guadagnoli, Germano
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Joao Nascimento, MD
mi
from
Bridgeport, CT
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Joao Nascimento, MD
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Clinical Research Center of CT/NY
mi
from
Danbury, CT
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Clinical Research Center of CT/NY
mi
from
Danbury, CT
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Arthritis and Rheumatic Disease Specialties
mi
from
Aventura, FL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis and Rheumatic Disease Specialties
mi
from
Aventura, FL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Arthritis & osteoporosis treatment center,PA
mi
from
Orange Park, FL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis & osteoporosis treatment center,PA
mi
from
Orange Park, FL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Rheumatology Associates of Central Florida
mi
from
Orlando, FL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rheumatology Associates of Central Florida
mi
from
Orlando, FL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
The Arthritis Center
mi
from
Palm Harbor, FL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Arthritis Center
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Sarasota Arthritis Research Center
mi
from
Sarasota, FL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Arthritis and Rheumatology of Georgia
mi
from
Atlanta, GA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis and Rheumatology of Georgia
mi
from
Atlanta, GA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Boise Rheumatology/ Intermountain Research Center, Inc
mi
from
Boise, ID
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Boise Rheumatology/ Intermountain Research Center, Inc
mi
from
Boise, ID
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Coeur D'Alene Arthrit Clin
mi
from
Coeur D Alene, ID
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Coeur D'Alene Arthrit Clin
mi
from
Coeur D Alene, ID
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Quincy Medical Group
mi
from
Quincy, IL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Quincy Medical Group
mi
from
Quincy, IL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Rockford Orthopedic Associates, LTD
mi
from
Rockford, IL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Rockford Orthopedic Associates, LTD
mi
from
Rockford, IL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
The Arthritis Center
mi
from
Springfield, IL
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
The Arthritis Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Klein & Associates, MD, PA
mi
from
Cumberland, MD
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Klein & Associates, MD, PA
mi
from
Cumberland, MD
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Clinical Pharmacology Study Group
mi
from
Worcester, MA
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Shores Rheumatology, P. C.
mi
from
St. Clair Shores, MI
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Shores Rheumatology, P. C.
mi
from
St. Clair Shores, MI
Click here to add this to my saved trials
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated:  11/5/2015
Arthritis Assoicates Of Mississippi
mi
from
Jackson, MS
Methotrexate-Inadequate Response Study
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
Status: Enrolling
Updated: 11/5/2015
Arthritis Assoicates Of Mississippi
mi
from
Jackson, MS
Click here to add this to my saved trials